This Biotech with Breakout MS Drug Draws Big Investment
A breakout multiple sclerosis drug can change a biotech's trajectory. This article digs into an $8 million investment...
Explore criteria to identify altcoins safe for long-term holding, including fundamentals, liquidity, and community support. Start evaluating with confidence.
27,729 articlesA breakout multiple sclerosis drug can change a biotech's trajectory. This article digs into an $8 million investment...
Oil rises to $104.07 per barrel on May 8, 2026, fueling questions about costs for drivers and investors. This report ...
A CNBC analyst argues that a pivotal policy move on April 9 reshaped the S&P 500’s trajectory, turning volatility int...
A high-quality, short-duration AAA CLO ETF is drawing attention by offering more income than 3-month Treasuries. For ...
Coinbase CEO Brian Armstrong sparks a polarized debate by asking if Bitcoin's bottom is in, triggering thousands of v...
Coinbase’s latest metrics reveal retail traders are accumulating BTC and ETH despite volatility, while institutions d...
A once-dismissed Google-backed AI fund has closed a $220 million fifth fund, illustrating how the seeds of AI investi...
Insider activity is part of every bank’s life. This guide explains how to read Form 4 disclosures and what they may m...
A biotech stock has surged 355%, catching the eye of every investor from day traders to pension funds. A prominent he...
Two big market events could move stocks this month. Learn how a Federal Reserve decision and the latest inflation and...
Sen. JD Vance faulted the Trump administration's handling of Epstein-related documents, calling out missteps in commu...
Tech leadership returns as Nvidia and Meta strengthen AI bets. This rally lifted major indexes and helped smaller gro...